A novel selective USP1 inhibitor coupled with a novel response biomarker

Discovery of a novel KAT6A/B inhibitor with anti-tumor activity coupled with novel response biomarkers

Integrative Proteomic Profiling in High-Grade Serous Ovarian Carcinoma: Unraveling Biomarkers and Therapeutic Targets

A large scale proteogenomic atlas for precision oncology

A novel USP1 inhibitor coupled with a novel proteomic response biomarker for precision oncology therapy-poster

A novel USP1 inhibitor coupled with a novel proteomic response biomarker for precision oncology therapy-video

Phospho-proteomic dynamics reveal DNA damage and repair signatures of drug sensitivity-poster

A large scale proteogenomic atlas for precision oncology research-poster

A large scale proteogenomic atlas for precision oncology research-video

Proteomics driven biomarker discovery for high-grade serous ovarian carcinoma from archived tissue specimens - poster

Proteomics driven biomarker discovery for high-grade serous ovarian carcinoma from archived tissue specimens - video

Proteomics platform identifies vulnerabilities for DNA damage repair drugs

Functional impact of protein-RNA variation in clinical cancer analyses

AACR 2023- Predictive biomarker discovery method to bridge the gap between preclinical disease model dose-response and clinical trials

AACR 2023- What can we learn from phosphoproteomics compared to transcriptomics in DNA damage and other processes?

ASMS 2022- Artifical intelligence and proteomics: predicting genome-wide perturbation response

Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification

Proteogenomics of glioblastoma associates molecular patterns with survival